7th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 19-21, 2026 | Boston, Massachusetts, USA
Carbamazepine
This drug is used to treat epilepsy and diseases that induce seizures because it contains anticonvulsant characteristics. It is the medication that is prescribed in oral dose forms available including chewable tablets, immediate-release tablets, extended-release tablets, and extended-release capsules. There is also an intravenous (IV) form available. It is also a generic medication. Oftentimes, generic drugs are less expensive than name brands. The brand-name medicine may not always be available in every dose form or strength. Schizophrenia is also treated with it in combination with several medications. It is furthermore used as a second-line drug for the treatment of the bipolar disorder. Some common side effects of carbamazepine include constipation, tiredness, drowsiness, and disorders of voluntary movement.
Frederick J Goldstein
Philadelphia College of Osteopathic Medicine, United States
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College and NEALAC Clinic , United States
John Michael Weber
Trauma Healed Life Coach, United States
Denis Larrivee
University of Navarra, Spain
Steve Cohen
Medvesta Hypnosis Healthcare, United States
Andrew Drasen
A Vision of Hope Media, United StatesSubmit your abstract Today
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States
Title : The effect of Balint training on self-efficacy and empathy among medical students and the moderator role of personality traits and choice of specialty
Meni Koslowsky, Ariel University, Israel
Title : Sexualizing anxiety and anxiolytic sex: Misattribution of arousal
Sam Vaknin, Commonwealth Institute of Advanced Professional Studies, United Kingdom
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Christopher Ashton, TeDDs on Chapel, Centre for Recovery, Canada
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GoodNeighbor LLC, United States